Search Results - D. Heid

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    P489: THE LONG NON-CODING RNA LINC01547 PROMOTES PROLIFERATION, CLONOGENICITY, AND CELL CYCLE PROGRESSION IN ACUTE MYELOID LEUKEMIA by S. M. N. Zimmermann, M. F. Blank, D. Heid, M. Bruckmann, C. Müller-Tidow, J. Krijgsveld

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  2. 2

    P414: RNA MODIFICATION-FOCUSED CRISPR-CAS9 SCREEN REVEALS POTENTIAL THERAPEUTIC TARGETS MEDIATING CHEMORESISTANCE IN AML by M. Kienhöfer, C. Pauli, S. Delaunay, C. Rohde, M. F. Blank, D. Heid, M. Frye, C. Müller-Tidow

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  3. 3

    P382: PTK2B MEDIATES TYROSINE KINASE INHIBITOR DRUG RESISTANCE IN AML ASSOCIATED WITH ALTERED MIGRATION AND ADHESION PROPERTIES by C. Allert, S. Zimmermann, S. Göllner, D. Heid, M. Bruckmann, M. Janssen, B. Besenbeck, J. Krijgsveld, C. Müller-Tidow, M. F. Blank

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  4. 4

    P490: SNORNA-DERIVED RNAS (SDRNAS) ARE IMPORTANT DRIVERS OF LEUKEMOGENESIS AND LEUKEMIC MAINTENANCE IN AML by R. Zinz, C. Rohde, D. Heid, M. Bruckmann, M. Bornhäuser, C. Röllig, U. Platzbecker, C. Baldus, H. Serve, F. Zhou, C. Pabst, C. Müller-Tidow, M. F. Blank

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  5. 5

    P454: VENETOCLAX AND GILTERITINIB SYNERGIZE IN FLT3 WILDTYPE ACUTE MYELOID LEUKEMIA BY SUPPRESSION OF MCL-1 VIA COMBINED AXL AND FLT3 TARGETING by C. Schmidt, M. Janssen, P.-M. Bruch, M. F. Blank, C. Rohde, A. Waclawiczek, S. Renders, D. Heid, S. Göllner, L. Vierbaum, K. Weidenauer, S. Herbst, M. Knoll, C. Kolb, B. Besenbeck, M. Fabre, M. Gu, R. Schlenk, F. Stölzel, M. Bornhäuser, C. Röllig, U. Platzbecker, C. Baldus, H. Serve, T. Sauer, S. Raffel, C. Pabst, G. Vassiliou, B. Vick, I. Jeremias, A. Trumpp, J. Krijgsveld, C. Müller-Tidow, S. Dietrich

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


Search Tools: